Efficacy of Topical Sirolimus (Rapamycin) for the Treatment of Microcystic Lymphatic Malformations

被引：35

作者：

Ivars, Marta ^{[1
]}

Redondo, Pedro ^{[1
]}

机构：

[1] Univ Navarra Clin, Vasc Anomalies Ctr, Dept Dermatol, Pamplona, Spain

来源：

JAMA DERMATOLOGY | 2017年 / 153卷 / 01期

关键词：

MAMMALIAN TARGET;

D O I：

10.1001/jamadermatol.2016.3697

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：103 / 105

页数：4

共 5 条

[1] Formulation and characterization of a 0.1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas [J].

Bougueon, Guillaume ;

Lagarce, Frederic ;

Martin, Ludovic ;

Pailhories, Helene ;

Bastiat, Guillaume ;

Vrignaud, Sandy .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 509 (1-2) :279-284

[2] Sirolimus for the Treatment of Complicated Vascular Anomalies in Children [J].

Hammill, Adrienne M. ;

Wentzel, MarySue ;

Gupta, Anita ;

Nelson, Stephen ;

Lucky, Anne ;

Elluru, Ravi ;

Dasgupta, Roshni ;

Azizkhan, Richard G. ;

Adams, Denise M. .

PEDIATRIC BLOOD & CANCER, 2011, 57 (06) :1018-1024

[3] Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis [J].

Huber, S. ;

Bruns, C. J. ;

Schmid, G. ;

Hermann, P. C. ;

Conrad, C. ;

Niess, H. ;

Huss, R. ;

Graeb, C. ;

Jauch, K-W ;

Heeschen, C. ;

Guba, M. .

KIDNEY INTERNATIONAL, 2007, 71 (08) :771-777

[4] Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: Phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial [J].

Marques, Laura ;

Nunez-Cordoba, Jorge M. ;

Aguado, Leyre ;

Pretel, Maider ;

Boixeda, Pablo ;

Nagore, Eduardo ;

Baselga, Eulalia ;

Redondo, Pedro .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (01) :151-U295

[5]

Shirazi Farheen, 2007, Lymphatic Research and Biology, V5, P233, DOI 10.1089/lrb.2007.1012

← 1 →